PURE logo

PURE PURE Bioscience, Inc.

Other OTC · Chemicals · Basic Materials

$0.06
+0.00 (+1.69%)

PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company’s technology platform contains silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.…

Market Cap: $7.80Mwww.purebio.com

Price

No data yet.

Social Signal Score

54
5d
—
30d
65
2 mentions
—
60d
48
5 mentions
—
90d
49
7 mentions
—
news: 7

Analyst Ratings

1 analyst
Holdconsensus
Strong Buy 0Buy 0Hold 1Sell 0Strong Sell 0

Revenue

$660.0K+24.29%
$312.0K$1.52M$2.74M$3.95M
Oct 2016Jul 2026

Analyst Estimates

FY2025
$2.88
$2.88–$2.88
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Jeff Kitchell
Sector
Basic Materials
Industry
Chemicals
Employees
11
Beta
0.22
Country
US
Piotroski score
2 / 9 (Weak)
Altman Z-score
-172.42
www.purebio.com